Millipore Sigma Vibrant Logo

218772 Caspase Inhibitor Set II - Calbiochem

Caspase Inhibitor Set II - Calbiochem: SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.
Primary Target: caspase-1, caspase-2, caspase-4, caspase-5, caspase-6, caspase-7, caspase-8, caspase-9
View Products on Sigmaaldrich.com
218772
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Eingeschränkte Verfügbarkeit Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information
      Description
      Overview

      This product has been discontinued.



      A set of eight cell-permeable, irreversible inhibitors of various caspase-family proteases. Contains 250 µg each of Caspase-1 Inhibitor VI, Z-YVAD-FMK (Cat. No. 218746); Caspase-2 Inhibitor I, Z-VDVAD-FMK (Cat. No. 218744); Caspase-3 Inhibitor II, Z-DEVD-FMK (Cat. No. 264155); Caspase-5 Inhibitor I, Z-WEHD-FMK (Cat. No. 218753); Caspase-6 Inhibitor I, Z-VEID-FMK (Cat. No. 218757); Caspase-8 Inhibitor II, Z-IETD-FMK (Cat. No. 218759); Caspase-9 Inhibitor I, Z-LEHD-FMK (Cat. No. 218761); and Caspase Inhibitor III, Boc-D-FMK (Cat. No. 218745). Supplied with a data sheet.
      Catalogue Number218772
      Brand Family Calbiochem®
      References
      ReferencesThornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
      Humke, E.W., et al. 1998. J. Biol. Chem. 273, 15702.
      Takahashi, A., et al. 1997. Exp. Cell Res. 231, 123.
      Thornberry, N.A., et al. 1997. J. Biol. Chem. 272, 17907.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Thornberry, N.A., et al. 1992. Nature 356, 768.
      Product Information
      FormSolid
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary Targetcaspase-1, caspase-2, caspase-4, caspase-5, caspase-6, caspase-7, caspase-8, caspase-9
      Secondary targetgranzyme B
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage -20°C
      Protect from Moisture Protect from moisture
      Do not freeze Ok to freeze
      Special InstructionsFrom Catalog:
      Desc. Field- added "A set of eight cell-permeable, irreversible inhibitors of various caspase-family proteases
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      218772 0

      Documentation

      Caspase Inhibitor Set II - Calbiochem Analysenzertifikate

      TitelChargennummer
      218772

      Literatur

      Übersicht
      Thornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
      Humke, E.W., et al. 1998. J. Biol. Chem. 273, 15702.
      Takahashi, A., et al. 1997. Exp. Cell Res. 231, 123.
      Thornberry, N.A., et al. 1997. J. Biol. Chem. 272, 17907.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Thornberry, N.A., et al. 1992. Nature 356, 768.

      Broschüre

      Titel
      Caspases and other Apoptosis Related Tools Brochure
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision04-June-2008 RFH
      DescriptionApoptosis is a normal process in development and morphogenesis. Many cells can be activated to undergo apoptosis following the interaction of selected ligands with cell surface receptors. Receptor-mediated apoptosis involves the activation of caspases (cysteine-containing aspartate-specific proteases). A distinctive feature of caspases is the requirement of an aspartic acid residue in the substrate P1 position.

      Caspase inhibitors act by binding to the active site of caspases and form either a reversible or an irreversible linkage. Caspase inhibitor design includes a peptide recognition sequence attached to a functional group such as an aldehyde (CHO), chloromethylketone (CMK), fluoromethylketone (FMK), or fluoroacyloxymethylketone (FAOM). Caspase inhibitors with a CHO group are reversible and those with a CMK, FMK, or FAOM group are irreversible. FMK exhibits slightly less reactivity than CMK and therefore is more specific for the enzyme being inhibited.
      FormSolid
      Storage Protect from moisture
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFrom Catalog:
      Desc. Field- added "A set of eight cell-permeable, irreversible inhibitors of various caspase-family proteases
      Toxicity Standard Handling
      ReferencesThornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
      Humke, E.W., et al. 1998. J. Biol. Chem. 273, 15702.
      Takahashi, A., et al. 1997. Exp. Cell Res. 231, 123.
      Thornberry, N.A., et al. 1997. J. Biol. Chem. 272, 17907.
      Nicholson, D.W., et al. 1995. Nature 376, 37.
      Thornberry, N.A., et al. 1992. Nature 356, 768.